Search results for Nemolizumab
Nemolizumab Biosimilar – Anti-IL31RA mAb – Research Grade, ProteoGenix, PX-TA1376
Description of Nemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade General information on Anti-IL31RA[Homo sapiens] (Nemolizumab) Monoclonal Antibody Nemolizumab is investigated for the treatment of Atopic Dermatitis (AD).
Host
Reactivity
Applications
Conjugation
Nemolizumab, Abbexa, abx831336
Nemolizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL31RA, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Nemolizumab Biosimilar - Research Grade, ichor.bio, ICH5123
Detects human IL-31RA
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Nemolizumab (HV121016), abinScience, HV121016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.